(Circulation. 2001;104:1241.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Cardiovascular Research Group, Temple University School of Medicine, Philadelphia, Pa.
Correspondence to Kenneth B. Margulies, MD, Co-Director, Cardiovascular Research Group, Temple University School of Medicine, Room 805 MRB, 3420 North Broad St, Philadelphia, PA 19140. E-mail margul{at}unix.temple.edu
Background Recognizing that mechanical circulatory support with a left ventricular assist device (LVAD) induces changes in myocardial structure and contractile function, we examined whether there are changes in ventricular conduction and/or repolarization among failing human hearts after LVAD implantation.
Methods and Results We examined 12-lead electrocardiograms before surgery, immediately after LVAD placement, and at a delayed (>1 week) postoperative time point in 23 patients who were receiving LVAD support for refractory heart failure. The immediate effects of hemodynamic unloading via LVAD placement included a decrease in QRS duration from 117±6 to 103±6 ms (P<0.01), an increase in absolute QT duration from 359±6 to 378±8 ms (P<0.05), and an increase in the heart rate-corrected QT interval (QTc) from 379±10 to 504±11 ms (P<0.01). None of these immediate changes were observed among 22 patients undergoing routine coronary artery bypass grafting. With sustained cardiac unloading via LVAD support, there was a marked decrease in the QTc from 504±11 to 445±9 ms (P<0.001). Studies in isolated cardiac myocytes, obtained at the time of transplantation, confirmed that delayed decreases in heart rate-adjusted QTc were the result of decreases in action potential duration after LVAD support.
Conclusions Acute electrocardiogram responses to LVAD placement demonstrate the dependence of QRS and QT duration on load in the failing human heart. Delayed decreases in QTc and action potential duration reflect reversal of electrophysiologic remodeling in the failing heart. Shortening of the action potential duration likely contributes to the improved cellular contractile performance observed after sustained LVAD support.
Key Words: heart failure heart-assist device QT interval action potential calcium
This article has been cited by other articles:
![]() |
A. Hakeem, S. Bhatti, and Z. Samad QRS Duration in Patients Hospitalized for Worsening Heart Failure JAMA, October 22, 2008; 300(16): 1880 - 1880. [Full Text] [PDF] |
||||
![]() |
A. R. Travis, G. A. Giridharan, G. M. Pantalos, R. D. Dowling, S. D. Prabhu, M. S. Slaughter, M. Sobieski, A. Undar, D. J. Farrar, and S. C. Koenig Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iwasaki, A. Kawamoto, M. Ishikawa, A. Oyamada, S. Nakamori, H. Nishimura, K. Sadamoto, M. Horii, T. Matsumoto, S. Murasawa, et al. Dose-Dependent Contribution of CD34-Positive Cell Transplantation to Concurrent Vasculogenesis and Cardiomyogenesis for Functional Regenerative Recovery After Myocardial Infarction Circulation, March 14, 2006; 113(10): 1311 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Demolombe, C. Marionneau, S. Le Bouter, F. Charpentier, and D. Escande Functional genomics of cardiac ion channel genes Cardiovasc Res, August 15, 2005; 67(3): 438 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Margulies, S. Matiwala, C. Cornejo, H. Olsen, W. A. Craven, and D. Bednarik Mixed Messages: Transcription Patterns in Failing and Recovering Human Myocardium Circ. Res., March 18, 2005; 96(5): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Torre-Amione, F. Sestier, B. Radovancevic, and J. Young Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: Results of a randomized, controlled, phase II trial J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1181 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pieske Reverse remodeling in heart failure - fact or fiction? Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D66 - D78. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.M.N. Terracciano, J. Hardy, E.J. Birks, A. Khaghani, N.R. Banner, and M.H. Yacoub Clinical Recovery From End-Stage Heart Failure Using Left-Ventricular Assist Device and Pharmacological Therapy Correlates With Increased Sarcoplasmic Reticulum Calcium Content but Not With Regression of Cellular Hypertrophy Circulation, May 18, 2004; 109(19): 2263 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Margulies Blocking Stretch-Induced Myocardial Remodeling Circ. Res., November 28, 2003; 93(11): 1020 - 1022. [Full Text] [PDF] |
||||
![]() |
J. BORLAK and T. THUM Hallmarks of ion channel gene expression in end-stage heart failure FASEB J, September 1, 2003; 17(12): 1592 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. McGowan, C. B. Scott, A. Mu, R. J. McCormick, D. P. Thomas, and K. B. Margulies Unloading-induced remodeling in the normal and hypertrophic left ventricle Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2061 - H2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vrtovec, R. Delgado, A. Zewail, C. D. Thomas, B. M. Richartz, and B. Radovancevic Prolonged QTc Interval and High B-Type Natriuretic Peptide Levels Together Predict Mortality in Patients With Advanced Heart Failure Circulation, April 8, 2003; 107(13): 1764 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Houser and K. B. Margulies Is Depressed Myocyte Contractility Centrally Involved in Heart Failure? Circ. Res., March 7, 2003; 92(4): 350 - 358. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |